Molecular and Genomic Profiling of Head and Neck Tumors (NCT00200486)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Stelby Augustine — The Bronx, New York

📞 Contact the Study Coordinator

Phone: (718) 920-7054

Email: staugust@montefiore.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Head and Neck Neoplasms

• Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) — La Jolla, California
• Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC) — Orlando, Florida
• Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC — Chicago, Illinois
• EMST in Patients Undergoing CRT for HNCA — Milwaukee, Wisconsin
• Head and Neck Cancer Study Project in the Geriatric Population — Providence, Rhode Island

Explore by condition: All Head and Neck Neoplasms clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.